+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Sanofi (SAN) - Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 73 Pages
  • March 2018
  • GlobalData
  • Sanofi S.A.
  • ID: 4489595
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Sanofi (SAN) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description - A detailed description of the company’s operations and business divisions.

  • Corporate strategy - Summarization of the company’s business strategy.

  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.

  • Company history - Progression of key events associated with the company.

  • Major products and services - A list of major products, services and brands of the company.

  • Key competitors - A list of key competitors to the company.

  • Key employees - A list of the key executives of the company.

  • Executive biographies - A brief summary of the executives’ employment history.

  • Key operational heads - A list of personnel heading key departments/functions.

  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

  • Key manufacturing facilities - A list of key manufacturing facilities of the company.


Highlights

Sanofi is a healthcare company, which focuses on researching, developing, manufacturing and marketing of a wide range of medicines and vaccines. Its product portfolio includes medicines for the treatment of cancer, diabetes, rare diseases, multiple sclerosis and cardiovascular diseases; human vaccines for protection against various bacterial and viral diseases; and other products. The major products of the company include Aubagio, Lantus, Lovenox, Plavix and others. Sanofi also offers consumer healthcare products for digestion; allergy; cough, cold, flu and sinus; pain; women’s health; and vitamins, minerals and supplements. It has operations across Europe, the Americas, Asia-Pacific, Africa and the Middle East. Sanofi is headquartered in Paris, France.

Sanofi Key Recent Developments

Mar 15, 2018: Sanofi Successfully Prices EUR 8 Billion Of Bond Issues
Mar 06, 2018: Sanofi’s Board of Directors Proposes Appointment of Emmanuel Babeau as New Independent Director
Feb 07, 2018: Sanofi Delivers 2017 Business EPS in line with Guidance
Jan 30, 2018: NIH launches partnership to improve success of clinical trials for patients with Parkinson’s disease
Jan 19, 2018: Sanofi Appoints Dominique Carouge Executive Vice President Head of Business Transformation and Member of the Executive Committee

Reasons to buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.

  • Understand and respond to your competitors’ business structure and strategies with this detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.


Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • Sanofi - Key Facts

  • Sanofi - Key Employees

  • Sanofi - Key Employee Biographies

  • Sanofi - Major Products and Services

  • Sanofi - History

  • Sanofi - Company Statement

  • Sanofi - Locations And Subsidiaries

  • Head Office

  • Other Locations & Subsidiaries

  • Joint Venture


Section 2 - Company Analysis
  • Company Overview

  • Sanofi - Business Description

  • Business Segment: Consumer Health

  • Overview

  • Performance

  • Business Segment: Pharmaceuticals

  • Overview

  • Performance

  • Key Stats

  • Business Segment: Vaccines

  • Overview

  • Performance

  • Key Stats

  • Geographical Segment: Emerging Markets

  • Target Markets

  • Performance

  • Geographical Segment: Europe

  • Target Markets

  • Performance

  • Geographical Segment: Rest of the World

  • Target Markets

  • Performance

  • Geographical Segment: United States

  • Performance

  • R&D Overview

  • Sanofi - Corporate Strategy

  • Sanofi - SWOT Analysis

  • SWOT Analysis - Overview

  • Sanofi - Strengths

  • Sanofi - Weaknesses

  • Sanofi - Opportunities

  • Sanofi - Threats

  • Sanofi - Key Competitors


Section 3 - Company’s Lifesciences Financial Deals and Alliances
  • Sanofi, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

  • Sanofi, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018

  • Sanofi, Recent Deals Summary


Section 4 - Company’s Recent Developments
  • Mar 15, 2018: Sanofi Successfully Prices EUR 8 Billion Of Bond Issues

  • Mar 06, 2018: Sanofi’s Board of Directors Proposes Appointment of Emmanuel Babeau as New Independent Director

  • Feb 07, 2018: Sanofi Delivers 2017 Business EPS in line with Guidance

  • Jan 30, 2018: NIH launches partnership to improve success of clinical trials for patients with Parkinson’s disease

  • Jan 19, 2018: Sanofi Appoints Dominique Carouge Executive Vice President Head of Business Transformation and Member of the Executive Committee

  • Jan 08, 2018: Evotec and Apeiron Achieve First Milestone in Immuno-Oncology Alliance with Sanofi

  • Jan 08, 2018: APEIRON and Evotec Achieve First Milestone in Immuno-Oncology Alliance With Sanofi

  • Dec 13, 2017: Sanofi presents R&D strategy and innovative pipeline

  • Dec 12, 2017: Striving to Defeat Dengue with Effective Vaccines

  • Dec 05, 2017: Sanofi and IBM Watson Health real-world analysis showed that individuals not achieving control on basal insulin within 12 months


Section 5 - Appendix
  • Methodology

  • About

  • Contact

  • Disclaimer


List of Tables
  • Sanofi, Key Facts

  • Sanofi, Key Employees

  • Sanofi, Key Employee Biographies

  • Sanofi, Major Products and Services

  • Sanofi, History

  • Sanofi, Subsidiaries

  • Sanofi, Joint Venture

  • Sanofi, Key Competitors

  • Sanofi, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

  • Sanofi, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018

  • Sanofi, Recent Deals Summary


List of Figures
  • Sanofi, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

  • Sanofi, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Samples

Loading
LOADING...

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Qiagen Marseille SA
  • Boehringer Ingelheim GmbH
  • Durata Therapeutics Inc
  • Sophiris Bio Inc
  • GlaxoSmithKline Plc
  • Novo Nordisk AS
  • Eli Lilly and Co
  • Bristol-Myers Squibb Co
  • AstraZeneca Plc
  • NewLink Genetics Corp
  • Merck & Co Inc
  • Receptos Inc
  • Novartis AG
  • F. Hoffmann-La Roche Ltd
  • Heska Corp
  • Groupe SOLACTIS SAS
  • Cardiome Pharma Corp

Related Topics

Copyright © 2002-2023 Research and Markets. All Rights Reserved.